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ABSTRACT Neurotransmitter vesicles contain biomolecules at extraordinarily high concentrations (hundreds of millimoles/
liter). Such concentrations can drive intermolecular associations, which may affect vesicular osmolarity and neuronal signaling.
Here we investigate whether aqueous serotonin (a monoamine neurotransmitter) forms oligomers at intravesicular concentra-
tions and whether these oligomers have speciﬁc spectroscopic signatures that can potentially be used for monitoring neuronal
storage and release. We report that, as serotonin concentration is increased from 60 mM to 600 mM, the normalized ﬂuorescence
spectrum of serotonin displays a growing long-wavelength tail, with an isoemissive point at 376 nm. The ﬂuorescence decay
is monoexponential with a lifetime of 4 ns at low concentrations but is multiexponential with an average lifetime of 0.41 ns at
600 mM. A 600 mM serotonin solution has 30% less osmolarity than expected for monomeric serotonin, indicating oligomer
formation. The proton NMR chemical shifts move upﬁeld by as much as 0.3 ppm at 600 mM compared to those at 10 mM,
indicating a stacking of the serotonin indole moieties. However, no intermolecular crosspeak is evident in the two-dimensional
NMR rotating frame Overhauser effect spectroscopy spectrum even at 600 mM, suggesting that oligomeric structures are
possibly weakly coupled. The appearance of a single peak for each proton suggests that the rate of interconversion between the
monomeric and the oligomeric structures is faster than 240 Hz. A stopped-ﬂow kinetic experiment also conﬁrms that the rate of
dissociation is faster than 100 ms. We conclude that serotonin forms oligomers at intravesicular concentrations but becomes
monomeric quickly on dilution. NMR signatures of the oligomers provide potential contrast agents for monitoring the activity of
serotonergic neurons in vivo.
INTRODUCTION
Serotonin is an important neurotransmitter involved in the
regulation of mood, sleep, appetite, circadian rhythm, and
cognition (1–3). Abnormalities of serotonergic neurotrans-
mission contribute to depression, suicidal behavior, impulsive
aggression, eating disorders, obsessive-compulsive disor-
ders, anxiety disorders, alcoholism, and other abnormalities
(3–5). Neuronal serotonin is packed to a concentration of
hundreds of millimoles/liter in the neurotransmitter vesicles
(6,7) and to a level of tens of millimoles/liter in some non-
neuronal vesicles (8). Quantum chemical studies indicate
that serotonin dimers, trimers, and higher oligomers may be
stabilized at high enough concentrations (N. Sathyamurthy,
Indian Institute of Technology Kanpur, personal communi-
cation, 2007). There is considerable experimental evidence
that the indole moiety of serotonin can also participate in
stacking interactions (9,10). The stacking of serotonin and
ATP molecules is also well documented (11–13). These re-
sults suggest that intravesicular serotonin may not exist in a
purely monomeric state.
The nature of intravesicular serotonin is interesting for
several reasons. An intermolecular association would de-
crease the effective osmotic pressure of serotonin in the ves-
icles. The typical osmolality of the cytoplasm is;290 mOsm
(14,15), but the concentration of serotonin itself in the vesicles
may exceed this value, as measured by spectroscopic (6) and
electrochemical approaches (7,16). In addition, there are
considerable amounts of ATP, buffer ions, and other solutes
present in the vesicles. An oligomeric association of seroto-
nin, spontaneously forming multimeric structures at higher
concentrations, may help the vesicle to balance the osmotic
pressure while packing in a large concentration of serotonin.
However, the functional form of serotonin that interacts
with the receptors in the postsynaptic cell and with the se-
rotonin transporters is thought to be monomeric, as these
exhibit submicromolar-level dissociation constants for sero-
tonin (17). If that is the case, then any oligomer should at
most be quasistable and should be able to quickly (within the
millisecond timescale of neurotransmission) dissociate when
diluted by exocytosis. It is therefore interesting to investigate
the nature and stability of intermolecular association of se-
rotonin in aqueous media.
Serotonin concentration quickly drops to submillimolar
levels when vesicles are exocytosed during neuronal activity
(17,18). However, the overall serotonin concentration in the
brain hardly changes, as it is well regulated by the continuing
cycle of synthesis, exocytosis, reuptake, and degradation
(18). Any experimental parameter that is sensitive to the local
dilution of serotonin would present an opportunity to spe-
ciﬁcally follow the activity of serotonergic neurons. A dis-
ruption of intermolecular association is expected to affect
the ﬂuorescence spectrum and the lifetime of serotonin and
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should also change its NMR chemical shift values. The
molecular geometry of the interaction can be understood by
a rotating frame Overhauser effect spectroscopy (ROESY)
type of experiment if the coupling strengths are adequate and
if the complex is stable in the timescale of the transfer of
magnetization. Fluorescence measurements can in principle
have the resolution and sensitivity to follow serotonin release
from a single cell (6,8,19), and NMR measurements have the
potential to follow such release in a noninvasive manner in
vivo. Existing technologies, such as functional magnetic
resonance imaging, do not allow the direct monitoring of the
activity of speciﬁc neuronal subtypes. Positron emission to-
mography and single photon emission computed tomography
imaging allow one to monitor the uptake of radiolabeled
serotonin but do not directly measure serotonin exocytosis
(20). Capillary electrophoresis can analyze serotonin from
extracts of biological tissue, including single cells (21–23),
but this method would not be applicable for live cells. Here
we explore the optical and NMR spectroscopic properties of
serotonin as a function of concentration, with the dual aims of
understanding the nature of serotonin at intravesicular con-
centrations and of identifying spectral signatures associated
with serotonin dilution.
MATERIALS AND METHODS
Materials
Serotonin hydrochloridewas purchased fromBiosynthAG (Staad, Switzerland).
Puriﬁed water (from a Milli-Q puriﬁer system, Millipore, Billerica, MA) was
used throughout to prepare the solutions. To avoid oxidation, nitrogen gas was
bubbled through the water before the solutions were prepared. Various con-
centrations of serotonin hydrochloride salt were prepared, and the pH was de-
termined using pH test strips (Sigma Chemicals, St. Louis, MO).
Methods
Steady-state measurements
The ﬂuorescence spectra at several concentrations were measured in a SPEX
Fluoromax 3 spectrometer (Jobin Yvon Horiba, Tokyo, Japan) using a 103
2-mm path-length quartz cuvette and using a slit with a nominal band pass of
5 nm. Steady-state ﬂuorescence spectra of several concentrations of seroto-
nin ranging from 60 mM to 600 mM were recorded. All experiments were
performed at room temperature. Background intensities were negligible but
were subtracted as routine.
Simulation of the ﬂuorescence spectra
The expected ﬂuorescence spectra at high concentration could be simulated
from the low-concentration data, assuming no change in the spectral prop-
erties. We needed to account for the absorption of the excitation and the
reabsorption of the emission by the concentrated solution. The simulations
were carried out using the Origin 7.0 software (OriginLab, Northampton,
MA). The absorbances for all concentrations ci were calculated using 1 mM
serotonin solution as a standard. The ﬂuorescence spectrum used for this
calculation was recorded from a dilute (60 mM) serotonin solution. The
area normalized ﬂuorescence spectrum [Nðc; lÞ] with the necessary correc-
tions was simulated using Eq. 1. This treatment follows that of MacDonald
et al. (24):
Nðc; lÞ ¼ Fðc; lÞ=
Z
Fðc; lÞdl; (1)
where Fðc;lÞ is given by
Fðc; lÞ ¼ Fðx; lÞ3 ð1=xÞ3 ð1 10Aðl;cÞÞ=eðlÞ;
where Fðx; lÞ is the raw ﬂuorescence of a standard serotonin solution of low
concentration (xmM,where x¼ 60 in our case),Aðl; cÞ is the absorption for a
given concentration c of serotonin solution (scaled from 1 mM experimental
data) for a 2-mm path-length cuvette over all wavelengths l; and eðlÞ is the
molar absorption coefﬁcient at wavelength l:
Time-resolved measurements
Time-resolved lifetime measurements are carried in a standard 10 3 2-mm
path-length cuvette. Details of the apparatus are described elsewhere (25).
Brieﬂy, the excitation wavelength is 285 nm, which was obtained by dou-
bling the 575 nm fundamental produced from aNd:YAG-pumped rhodamine
6G dye laser (Spectra Physics, model No. 375B, Mountain View, CA) op-
erating at 4 MHz. The emission monochromator was set to 420 nm. The
excitation polarizer was oriented in the vertical position, whereas the emis-
sion polarizer was set to the magic angle (54.7). A dilute scattering solution
(milk powder solution) was prepared to acquire the instrument response
function of the entire detection system. All lifetime data are deconvolved
with the instrument response function and then ﬁtted using a multi-
exponential ﬁtting routine. Lifetime data were also analyzed with a maxi-
mum entropy method (MEM) ﬁtting routine (26).
NMR measurements
Concentration-dependent one-dimensional (1D) NMR experiments were
performed in a Bruker Avance 800 MHz and 500 MHz spectrometer using a
presaturation pulse sequence for solvent suppression. All two-dimensional
(2D) experiments were done in a Bruker Avance 800 MHz (Bruker/BioSpin,
Billerica, MA) spectrometer using the ROESY pulse sequence, with different
mixing times (50, 150, 350, and 450 ms). Deuterium oxide (Sigma Aldrich,
St. Louis, MO) was used as a locking solvent. All experiments were carried
out at room temperature (25C).
Osmometry
Osmometry was performed using a microvolume osmometer (Model Auto-
matika, Roebling, Berlin, Germany). Osmolality of the different concentra-
tions of serotonin hydrochloride salt solutions ranging from 6mM to 600mM
wasmeasured.As a control, the osmolalityof sodiumchloride (S.D.Fine-chem.,
Mumbai, India) solution was measured over a similar concentration range.
The osmolality of water was calibrated to zero in all measurements. All ex-
periments were performed at room temperature (25C).
Stopped-ﬂow kinetic experiments
Stopped-ﬂow experiments were carried out using a fast stopped-ﬂow ﬂuo-
rescence spectrometer (Bio-Logic, SFM 300, Grenoble, France). Serotonin
solution (600 mM) was diluted to 6 mM using nitrogen-bubbled puriﬁed
water. A 100-fold dilution required the mixing of 1.287 ml of water to 13 ml
of serotonin solution. The ﬂow rate was 15 ml/s, yielding a mixing time of
;100 ms. Time-resolved ﬂuorescence counts of serotonin were monitored
using an emission ﬁlter of 335 nm having a band pass of 70 nm. The exci-
tation monochromator was ﬁxed at 270 nm with the slit set to 5 nm. All
experiments were performed at room temperature. Background intensities
were negligible but were subtracted from all the data. All data points were
recorded with 1-ms time resolution.
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RESULTS
Steady-state ﬂuorescence spectroscopy
Emission spectra are recorded as a function of concentration
for concentrations ranging from 1 mM to 600 mM, with the
excitation ﬁxed at 270 nm. The area-normalized spectra are
plotted in Fig. 1. At very low concentrations (between 1 mM
and 1 mM), the normalized spectra completely overlap with
each other. These data have not been shown separately. At
higher concentrations, the long-wavelength tail slowly in-
creases in amplitude. The normalized ﬂuorescence emission
spectra show an apparent isoemissive point at ;376 nm. In
addition, a small shift in the peak of the emission spectra is
also observed as the concentration increases. The peak is at
339 nm for 1 mM serotonin, but it shifts to 345 nm for 600
mM serotonin.
Fluorescence lifetime measurements
An emerging ﬂuorescent species is expected to have a distinct
signature in a ﬂuorescence lifetime assay. The ﬂuorescence
intensity decay after a near-d pulse excitation is measured
using the time-correlated single-photon counting technique at
420 nm emission wavelength. All lifetime decay data are
ﬁtted using a discrete number of components. The decay
recorded from a low concentration serotonin solution (62
mM) ﬁts a single exponential (see Fig. 2, inset) with a time
constant of 4.0 ns (Table 1). This remains similar for all
concentrations up to;2mM. At concentrations above 5mM,
this value shifts to ;3 ns. The lifetime can be ﬁt by a single
exponential up to ;20 mM of serotonin concentration.
However, for concentrations.40 mM and up to 75 mM, the
data do not ﬁt well to a single exponential but can be ﬁtted
with two exponentials. Concentrations above 75 mM require
three exponentials (e.g., 600 mM, see Fig. 2, inset). Average
lifetime decreases monotonically with concentration and
becomes;1.88 ns at 75 mM and as small as;400 ps at 600
mM (Table 1). To examine whether the ﬁnite number of
components provides a reasonable interpretation of the data,
we also ﬁt our data with a quasicontinuous distribution of
lifetimes using a MEM-based analysis routine (26). The
MEM analysis (Fig. 2) shows a single peak up to 20 mM, two
peaks up to 75 mM, and three peaks above it. The MEM
analysis is thus consistent with our interpretation of the
lifetime data in terms of a ﬁnite number of components.
Osmometry
Osmolality of a solution is the measure of the total number of
particles dissolved in the solvent and hence could be used as
an indicator for intermolecular association. A 1-molal solu-
tion of both serotonin hydrochloride and sodium chloride are
expected to have an osmolality of 2 Osm. At concentrations
below 150 mM, the osmolality of a serotonin solution be-
haves as expected (Fig. 3). At higher concentrations, the
osmolality starts deviating from linearity. The osmolality is
14% lower for 200 mM and 30% lower for 600 mM com-
pared with the expected value. However, the measured os-
molality of 600 mM sodium chloride solution is within 5% of
the expected value (Fig. 3). We note that osmolality and os-
molarity of the serotonin solutions differ by,10% up to 600
mM of serotonin solution. The solubility of serotonin at 600
mM is checked by centrifuging the solution at 14,0003 g for
;2 h. The absorbance of the solution remains unchanged
FIGURE 1 Area-normalized ﬂuorescence emission spec-
tra of serotonin at different concentrations: 60 mM (open
inverted triangles), 1 mM (solid squares), 12.5 mM (open
squares), 25 mM (solid circles), 50 mM (open circles), 100
mM (solid triangles), 200 mM (open triangles), 300 mM
(solid stars), 400 mM (open stars), 500 mM (solid dia-
monds), and 600 mM (open diamonds). The isoemissive
point at 376 nm is shown with the dotted vertical line.
(Inset) Simulated area-normalized emission spectra of se-
rotonin taking reabsorption of the emission into account; for
60 mM (open inverted triangles), 1 mM (solid squares), 50
mM (open squares), 100 mM (solid circles), 300 mM (open
circles), and 600 mM (solid triangles) serotonin. Reabsorp-
tion does not appreciably affect the spectra above 360 nm
and does not explain the characteristics of the experimen-
tally measured spectra.
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within errors (data not shown). In fact, serotonin remains
soluble at least up to 1 M (data not shown).
NMR spectroscopy
Serotonin has seven protons that are stable enough to give
clear signatures in an NMR spectrum (Fig. 4, inset). Emer-
gence of any new species at higher concentrations should
affect the proton NMR spectrum. We record the proton NMR
spectrum of serotonin at room temperature as a function of
concentration. Fig. 4 shows the spectrum for 10, 25, 50, 100,
150, 200, 300, 400, and 600 mM serotonin. The spectral
assignments are indicated on the top, and the numbers cor-
respond to the proton numbers described in the inset. The
assignments follow that of Krishnan and Balaram (27). All
peak amplitudes are normalized with respect to that of proton
7. The peak appearing ;4.5 ppm is caused by the proton
signal from water, which is sometimes not completely sup-
pressed by the saturation pulse. The chemical shifts of all the
protons change with concentration, but by different amounts
(Fig. 5). The NH proton suffers the largest change of ;0.3
ppm as the concentration goes from 10 mM to 600 mM. The
amplitude of this peak (relative to the amplitude of the pro-
tons in the alkyl chain) also increases with concentration.
Other protons that seem to undergo a signiﬁcant change of
FIGURE 2 Fluorescence lifetime distribution obtained
from a MEM-based analysis: 125 mM (open stars), 5 mM
(solid stars), 10 mM (open triangles), 20 mM (solid trian-
gles), 40 mM (open circles), 75 mM (solid circles), 150 mM
(open squares), and 600mM(solid squares). (Inset, panel A)
Peak normalized ﬂuorescence lifetime decay for 62 mM
(open squares) and 600 mM (open circles) serotonin solu-
tion ﬁtted with one exponential and three exponentials,
respectively (solid lines). (Inset, panel B) Residuals for the
three-component ﬁt for 600 mM serotonin. (Inset, panel C)
Residuals for the one-component ﬁt for 62 mM serotonin.
TABLE 1 Fluorescence lifetime of serotonin as a function
of concentrations
Concentration
(mM) t1 (ns) t2 (ns) t3 (ns) a1 a2 a3 tavg (ns) x
2
0.06 4.00 – – 1 – – 4.00 0.9
0.125 3.95 – – 1 – – 3.95 1.6
0.25 3.96 – – 1 – – 3.96 1.3
0.5 3.99 – – 1 – – 3.99 1.2
1 3.96 – – 1 – – 3.96 1.0
2 4.11 – – 1 – – 4.11 1.0
5 3.08 – – 1 – – 3.08 1.14
10 3.06 – – 1 – – 3.06 1.07
20 2.90 – – 1 – – 2.90 1.05
40 2.7 0.77 – 0.91 0.08 – 2.54 1.05
75 2.14 0.54 – 0.84 0.16 – 1.88 1.14
150 1.61 0.84 0.07 0.47 0.15 0.38 0.92 0.97
300 1.46 0.71 0.08 0.26 0.44 0.3 0.71 0.97
600 1.25 0.45 0.07 0.15 0.44 0.41 0.41 0.95
ti values are the different lifetime components, ai values are the corresponding
normalized amplitudes, tavg is the average lifetime, and x
2 is the reduced chi-
square value of the respective ﬁts for different concentrations of serotonin.
FIGURE 3 Osmolality as a function of serotonin hydrochloride concentra-
tion. Serotonin (solid squares) and sodium chloride solution (solid circles). The
dotted line is the theoretical osmolality for any salt of a monovalent cation.
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the chemical shifts (all in the upﬁeld direction) are those of
the alkyl chains and the proton attached to the pyrrole ring
(Fig. 5). On the other hand, the chemical shifts of the aro-
matic protons attached to the benzene ring change by com-
paratively smaller amounts (Fig. 5).
The serotonin solutions are prepared in pure water that
does not contain any pH-stabilizing buffer, as it is difﬁcult to
buffer such high concentration of solutes. However, we
monitor the pH of the solutions. A low concentration of se-
rotonin up to 10 mM has a pH of 7, but the pH becomes
somewhat acidic at higher concentrations (it reaches ;5.5 at
600 mM). We investigate whether the difference of pH
contributes to the observed change in the chemical shifts and
record the proton NMR spectrum of 60 mM serotonin at pH
1 and pH 9. The largest observed change in the chemical shift
(in the upﬁeld direction) is ;0.05 ppm (data not shown),
which is much less than the difference observed as a result of
the change in concentration.
FIGURE 4 Proton NMR spectra of serotonin as a func-
tion of concentration. The dotted vertical lines mark the
different proton peak positions for 10 mM serotonin. The
amplitude of each spectrum is normalized with respect to
proton 7. The numbers on top of each peak (for 600 mM)
correspond to speciﬁc protons of the serotonin molecule
(see inset). (Inset) Chemical structure of the serotonin
molecule with different protons marked from 1 to 7.
FIGURE 5 Changes in proton chemical shifts as a func-
tion of concentration. Proton 1 (solid stars), proton 2 (solid
circles), proton 3 (solid diamonds), proton 4 (solid squares),
proton 5 (open stars), proton 6 (open circles), and proton
7 (open squares); 10 mM serotonin is used as a baseline.
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2D NMR spectroscopy
The geometry of any emerging oligomeric species should be
manifested in the 2D NMR crosspeaks arising from the in-
termolecular proton-proton dipolar interactions. We record a
high-resolution 2D ROESY spectrum for both a low (6 mM)
and a high concentration (600 mM) specimen of serotonin
(data not shown). The spectra are recorded at several mixing
times (50, 150, 350, and 450 ms). The diagonal peaks in all
the spectra are identical to those assigned by the 1D NMR
spectrum. All the ROESY crosspeaks observed in the 600
mM spectrum are the same as those observed in the 6 mM
spectra and are expected from the monomeric structure of the
molecule.
Stopped-ﬂow kinetic experiments
The timescale of the dissociation of the putative oligomers can
be directly studied using a stopped-ﬂow apparatus. The 600
mM serotonin is diluted 100-fold (data not shown), and the
emission is monitored at 335 nm (excitation is at 270 nm). No
appreciable change in ﬂuorescence is observed beyond the
mixing time of 100 ms. This experiment puts an upper limit of
;100 ms for the dissociation time of the putative oligomers.
DISCUSSION
Steady-state ﬂuorescence spectra provide
evidence for a second species
The existence of an isoemissive point is a clear indication of
the coexistence of two different ﬂuorescent species. However,
at the concentrations used in this experiment, the inner ﬁlter
effect (caused by the absorption of the excitation light within
the sample cuvette) is considerable. The area-normalization
approach, used here, can circumvent the inner ﬁlter effect and
report the isoemissive point, if one does exist. We note that
the spectra would also be affected by the reabsorption of
the ﬂuorescence photons by other serotonin molecules. This
would change the observed spectra in a wavelength-dependent
manner and would shift the peak toward longer wavelengths.
We use simulations to investigate whether this can give rise to
the spectral features observed here.Wemeasure the absorption
spectra for a 1 mM solution and the ﬂuorescence spectrum of a
dilute (62 mM) solution, scale them by concentration, and use
Eq. 1 to get the simulated area-normalized spectra (Fig. 1,
inset). We see that this produces relatively small changes
above 360 nm, and does not produce an isoemissive point
anywhere. We infer that the experimentally observed iso-
emissive point at 376 nm implies the existence of a new spe-
cies. The increased amplitude at the longer wavelengths may
denote the emergence of dimeric (or higher oligomeric) spe-
cies, which typically have excited states at an energy that is
lower than that of the constituent monomers (28).
We note that the spectral shift of serotonin under different
solution conditions is well known. The serotonin emission
spectrum is somewhat pH dependent (29). Also, the oxidized
formof serotonin develops a long-wavelength shoulder (21,30).
However, the concentration-dependent shift observed here
differs from these observations. The change is observed even
when the serotonin spectra are recorded from a quick dilution
of a concentrated solution, suggesting that it cannot be a
simple oxidation process. Also, the pH of the solutions varies
between 5.5 and 7.0, which is not expected to substantially
change the serotonin emission spectrum (29).
Fluorescence lifetime data indicate the
emergence of at least two new species
A substantial change in the ﬂuorescence lifetime can indicate
the onset of intermolecular interactions. In the simplest case,
it can signify the increase of collisional self-quenching in a
medium of higher concentration. A plot of the inverse of the
lifetime versus the concentration is expected to be linear for a
typical Stern-Volmer-type quenching process (28). However,
that does not hold true in this case (not shown here, but can
easily be seen from the data presented in Table 1). Neither the
average nor the longest lifetime components shows an in-
verse linear variation with concentration. This indicates that
the reduction in the average lifetime is not caused by con-
centration-dependent quenching. Further, at concentrations
.40 mM, a single exponential component is inadequate to
describe the ﬂuorescence decay. Quenching is not expected
to lead to extra lifetime components (28). We therefore
conclude that collisional quenching, although undoubtedly a
contributor at the higher concentrations, cannot explain the
observed features of the ﬂuorescence lifetime.
On the other hand, formation of dimers and trimers at
higher concentrations is plausible, and these species in general
will have different lifetimes. Although the interpretation of
any lifetime decay data in terms of a ﬁnite number of com-
ponentsmay not be deﬁnitive, our data are also well supported
by the MEM analysis. The MEM analysis ﬁts the data to a
quasicontinuous distribution of lifetimes and clearly shows
separate peaks emerging at the higher concentrations. Above
150 mM, a third peak appears that signiﬁes the possible ex-
istence of a third species. We note that the existence of three
species would in general not lead to an isoemissive point in
the emission spectrum. However, if the third species has a
short lifetime, then its contribution to the steady-state ﬂuo-
rescence intensity may be small. Alternatively, if the spectra
of the second and third species are similar, then the iso-
emissive point may be preserved. In any case, both the steady-
state and the time-resolved ﬂuorescence data support the
emergence of a new, perhaps oligomeric, species of serotonin
at the concentrations prevalent inside neuronal vesicles.
Osmometry provides independent evidence for
intermolecular association
Serotonin hydrochloride in water dissociates into protonated
serotonin and Cl, so for each millimolal of dissolved sero-
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tonin, the osmolality of the solution would be 2 mOsm. This
is indeed observed for serotonin solutions up to 100mM (Fig.
3). Sodium chloride used here as a control shows a similar
near-linear behavior up to 600 mM (within an error of 5%).
However, serotonin clearly deviates from linearity above 100
mM and is 30% below the expected value at 600 mM. Be-
cause our solubility experiments show that serotonin remains
soluble at least up to 1 M, the osmometry results provide
independent evidence that serotonin at high concentrations
forms oligomeric structures that coexist with the monomers.
NMR spectroscopy suggests
stacking intermediates
1DNMR data show a change in the chemical shift values with
concentration. Considerable change occurs at concentrations
$150 mM, which coincides with the appearance of the third
peak in the lifetime distribution (Fig. 2) and the deviation from
linearity in the osmolality measurements. This correlation of
various parameters from different experiments indicates that
serotonin starts forming oligomers at concentrations $150
mM. We rule out a difference of pH (ranging from 7.0 at low
concentrations to 5.5 at the highest concentration) as a major
contributor to these changes because the chemical shift values
change at most by 0.05 ppm (in the upﬁeld direction) as the pH
is varied from 1.0 to 9.0. However, spatial proximity of the
individual monomers in an oligomer can easily cause such
shifts. Intermolecular hydrogen bonding and stacking inter-
actions would be the two most likely mechanisms underlying
serotonin oligomer formation. In quantum chemical studies,
hydrogen bonding by serotonin has been suggested to cause
dimer and trimer formation (N. Satyamurthy, Indian Institute
of Technology Kanpur, personal communication, 2007).
However, hydrogen bonding would be expected to cause the
chemical shifts to be downﬁeld (31), whereas we observe that
all the protons shift upﬁeld. The upﬁeld nature of the shifts
suggests a stacking interaction of the monomers, which arises
as a result of ring current interactions between the two aro-
matic rings (32). Indeed, many aromatic compounds with
similar structures (e.g., nucleic acids and ATP) are known to
undergo upﬁeld shifts because of stacking (33–35). In fact,
such upﬁeld shifts have been demonstrated by serotonin in
interactions with other aromatic molecules (9,12,36). In a
pioneering study, Viscio and Prestegard (11) measured the
transport of serotonin to the lumens of ATP-rich vesicles by
measuring the upﬁeld shift of the serotonin NMR spectrum as
it becomes complexed to the ATP. Such ATP-induced upﬁeld
shifts have also been observed in the granules of pig platelet
cells (13).We therefore suggest that the upﬁeld shifts observed
by us are caused by intermolecular stacking interactions be-
tween different serotonin monomers.
Possible structure of the serotonin oligomer
The magnitude of the stacking-induced changes in the
chemical shifts is expected to be a function of the size of the
aromatic rings, their mutual orientation, and the distances
between them (37). We observe that protons of the pyrrole
ring and those of the alkyl chain undergo larger changes in
their chemical shifts compared with those of the benzene
ring. This suggests a greater interaction among these moieties
in the stacked structure. The indole amide proton also grows
in relative strength with concentration (Fig. 5), which sug-
gests that this proton is partially protected by the oligomeric
structure formation at the higher concentrations. An alternate
possibility is that the relative strength of the amide proton
may change as a result of a change in the pH from 7.0 to 5.5
(between the low and the high concentration of serotonin).
However, we rule out this possibility because we do not
observe any substantial change in the amide signal strength as
the pH is varied from 5.5 to 7.0 (at low concentration, data
not shown). This is also expected because the pKa of the
indole proton is ;10.0 (29,38,39).
Stopped-ﬂow ﬂuorescence experiments show that the dis-
sociation of the oligomers takes place within the time reso-
lution of the mixing time of the instrument (;100 ms). This
indicates that the oligomers that form at high concentrations
are transient in nature and have a stability of,;100 ms. 1D
NMR data show a single peak for each proton at all con-
centrations. The largest chemical shift change between the
highest and the lowest concentrations studied is;0.3 ppm in
an 800-MHz spectrometer. This indicates that the exchange
between the two types of structures happens at a rate faster
than 240 Hz. The ROESY spectrum also fails to show any
intermolecular crosspeaks. Although there could be several
reasons for it, including inadequate coupling strength, an
explanation that is consistent with our stopped-ﬂow data and
the 1D NMR data is the low stability of these complexes. The
balance of evidence suggests that serotonin molecules form
a new oligomeric entity at high concentrations, most likely
by intermolecular stacking, but this entity has relatively low
stability (less than a few milliseconds). However, the geom-
etry of such a complex remains to be determined.
The implication of serotonin oligomer formation
Serotonin oligomer formation at intravesicular concentrations
has interesting biological and practical consequences. First,
the formation of oligomers would aid the ability of the cell to
pack very high concentrations of serotonin in submicrometer-
sized vesicles against cytosolic osmotic pressure. Our results
show that the osmolality of a high-concentration serotonin
solution is substantially lower than that expected for mono-
meric serotonin. We suggest that serotonin oligomer forma-
tion plays a signiﬁcant part in maintaining the extraordinarily
high concentrations of serotonin in mammalian neuronal
vesicles. We note there are alternative mechanisms that have
been proposed to explain the high concentration packing of
serotonin into the vesicles. For example, the amperometric
‘‘foot’’ signals observed inmast cell exocytosis are thought to
be a signature of the slow dissociation of the serotonin mol-
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ecules from the proteinaceous matrix (40,41). We also note
that there is some evidence that serotonin is associated with a
serotonin-binding protein in the vesicular lumen (42). The
presence of intracellular ions such as K1 and Fe21 (43) may
also serve as additional means for reducing osmolality. At
present it is not clear which, if any, of these is the dominant
mechanism.
The second important issue is the effect of such oligo-
merization on the timescale of serotonergic neuronal com-
munication. If the oligomers were stable, then the receptors
and the transporters of serotonin would have to interact with
an oligomeric serotonin molecule immediately after exocy-
tosis. However, the receptors and the transporters most likely
use monomeric serotonin as a substrate, given their sub-
micromolar binding afﬁnity for serotonin (17). The existence
of a stable oligomeric entity would then effectively reduce
the number of neurotransmitters in the neuronal vesicle. The
ROESY spectrum, the single peaks observed in the 1D NMR
data, and the stopped-ﬂow data all indicate that the dissoci-
ation of the oligomer happens in less than a few milliseconds.
Therefore, the receptors and the transporters may need to
interact only with monomeric serotonin during the timescale
of the neurotransmission event (about a few milliseconds).
Our results therefore suggest that nature has taken advantage
of a fast switch between oligomeric and monomeric forms of
serotonin to keep the vesicular osmolarity under control on
one hand and to keep neurotransmission appropriately fast
and efﬁcient on the other.
Finally, the spectral changes associated can potentially
allow serotonin-speciﬁc investigation of neurotransmission.
The serotonin ﬂuorescence from individual vesicles/vesicu-
lar clusters in live mammalian neurons can be effectively
detected with multiphoton excitation (6,19). In principle,
both the ﬂuorescence spectrum and the lifetime can be de-
termined, and serotonin dilution induced by exocytosis can
be followed in a quantitative manner. The NMR measure-
ments of dilution are perhaps even more interesting because
these can, in principle, be performed in vivo. At present, there
is no direct in vivo method to monitor neurotransmitter-
speciﬁc neurotransmission in the brain. NMR spectroscopy
of the brain may be able to record the differential signal as-
sociated with the change in the serotonin proton chemical
shifts when the serotonergic activity is high. It remains to be
tested whether the signal strength is enough to be recorded
above the brain background. However, some clinically rel-
evant situations are associated with large serotonin release
(such as amphetamine abuse) (44,45), and these may be ap-
propriate candidates for the exploration of this possibility.
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